Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CFMTI

Catalog No. T3482 Copy Product Info
Purity: 97.88%
🥰Excellent
CFMTI is a potent and selective metabotropic glutamate receptor (mGluR) 1 allosteric antagonist (IC50: 2.6 nM). The selectivity of CFMTI to mGluR1 is higher 2000-fold than mGluR5.

CFMTI

Copy Product Info
🥰Excellent
Catalog No. T3482

CFMTI is a potent and selective metabotropic glutamate receptor (mGluR) 1 allosteric antagonist (IC50: 2.6 nM). The selectivity of CFMTI to mGluR1 is higher 2000-fold than mGluR5.

CFMTI
Cas No. 864864-17-5
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$55In StockIn Stock
2 mg$79In StockIn Stock
5 mg$129In StockIn Stock
10 mg$189In StockIn Stock
25 mg$338In StockIn Stock
50 mg$479In Stock-
100 mg$668InquiryInquiry
1 mL x 10 mM (in DMSO)$143In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.88%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

CFMTI AI Summary
CFMTI has antagonist activity at human mGluR1 and mGluR5 receptors, with IC50 values of 3.5 nM and 5400.0 nM, respectively. It shows a logD value of 1.9, reflecting its distribution coefficient. In pharmacokinetic studies, the compound demonstrates high oral bioavailability in rats at 100%, a half-life of 0.6 hours following oral (3 mg/kg) or intravenous (1 mg/kg) administration, and a plasma clearance rate of 8.1 mL.min^-1.kg^-1. Additionally, CFMTI exhibits inhibitory activity against the SARS-CoV-2 3CL-Pro protease at 20 µM, with a 13.28% inhibition rate, and shows antiviral activity by reducing SARS-CoV-2 induced cytotoxicity in VERO-6 cells at 10 µM after 48 hours, with an inhibition rate of 0.04%..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
CFMTI is a potent and selective metabotropic glutamate receptor (mGluR) 1 allosteric antagonist (IC50: 2.6 nM). The selectivity of CFMTI to mGluR1 is higher 2000-fold than mGluR5.
Targets&IC50
mGluR:2.6 nM, mGluR1a (rat):2.3 nM
Chemical Properties
Molecular Weight349.36
FormulaC19H16FN5O
Cas No.864864-17-5
SmilesCc1c(nnn1-c1cccnc1F)-c1ccc2C(=O)N(Cc2c1)C1CC1
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 4.62 mg/mL (13.22 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8624 mL14.3119 mL28.6238 mL143.1188 mL
5 mM0.5725 mL2.8624 mL5.7248 mL28.6238 mL
10 mM0.2862 mL1.4312 mL2.8624 mL14.3119 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CFMTI | purchase CFMTI | CFMTI cost | order CFMTI | CFMTI chemical structure | CFMTI formula | CFMTI molecular weight